Allergic rhinitis
Conditions
Interventions
experimental group:Bifidobacterium triplex live bacteria treatment
control group:Placebo
Sponsors
Otolaryngology Head and Neck Surgery Listening Center / Listening and Speech Science Laboratory, West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
No minimum to 6 Years
Inclusion criteria
Inclusion criteria: 1. 60 participants with a history of allergic rhinitis between 0 and 6 years old. 2. Plan to have equal sex ratio, but not necessarily. 3. Patients with allergic rhinitis must be diagnosed by a doctor (allergist or general practitioner). 4. Within 24 months before the test, the patients shall submit the test results (whether skin acupuncture test or serum allergen specific IgE) that are sensitive to air allergen IgE.
Exclusion criteria
Exclusion criteria: 1. Patients with diabetes history; 2. Patients with gastrointestinal diseases; 3. Patients who have used antibiotic drugs and any known mental or neurological diseases in the past 6 weeks; 4. The patients with rupture or perforation of nasal septum.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Combined Symptoms and Medication Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| health-related quality of life by means of diaries; | — |
Countries
China
Contacts
Public ContactXueqiu Cao
Otolaryngology Head and Neck Surgery Listening Center / Listening and Speech Science Laboratory, West China Hospital of Sichuan University
Outcome results
None listed